Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Brandon S. Imber, MD, MA"'
Autor:
Brandon S. Imber, MD, MA, Ryka Sehgal, MD, Rachel Saganty, MD, Anne S. Reiner, MPH, A. Turan Ilica, MD, Emily Miao, PharmD, Bob T. Li, MD, Gregory J. Riely, MD, Helena A. Yu, MD, Katherine S. Panageas, DrPH, Robert J. Young, MD, Luke R.G. Pike, MD, DPhil, Nelson S. Moss, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100607- (2023)
Introduction: Patients with EGFR-mutant NSCLC have a high incidence of brain metastases. The EGFR-directed tyrosine kinase inhibitor osimertinib has intracranial activity, making the role of local central nervous system (CNS)-directed therapies, such
Externí odkaz:
https://doaj.org/article/eb50687c81bc4fa09768c4beb4a3d785
Autor:
Annemarie F. Shepherd, MD, Anthony F. Yu, MD, Michelle Iocolano, MD, Jonathan E. Leeman, MD, Aaron T. Wild, MD, Brandon S. Imber, MD, MA, Jamie E. Chaft, MD, Michael Offin, MD, James Huang, MD, James M. Isbell, MD, MSCI, Abraham J. Wu, MD, Daphna Y. Gelblum, MD, Narek Shaverdian, MD, Charles B. Simone, II, MD, Daniel Gomez, MD, Ellen Yorke, PhD, Andrew Jackson, PhD, Andreas Rimner, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 8, Pp 100209- (2021)
Introduction: Given the concern for cardiopulmonary toxicity in patients with NSCLC undergoing postoperative radiation therapy (PORT), the purpose of this study was to evaluate the association between heart dose and overall survival (OS) in patients
Externí odkaz:
https://doaj.org/article/aae79c56f33a4e87b7bc7fe74e987c31